Global Needle-Free Injectors Market Research Report 2022
Needle free injection technology (NFIT)is an extremely broad concept which include a wide range of drug delivery systems that drive drugs through the skin using any of the forces as Lorentz, Shock waves, pressure by gas or electrophoresis which propels the drug through the skin, virtually nullifying the use of hypodermic needle.
Due to the COVID-19 pandemic, the global Needle-Free Injectors market size is estimated to be worth US$ 206.4 million in 2021 and is forecast to a readjusted size of US$ 398.3 million by 2028 with a CAGR of 9.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Needle-Free Injectors market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Needle-Free Injectors landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Rise in prevalence of diabetes raises the demand for needle-free insulin delivery devices. Asia-Pacific offers lucrative opportunities for the market growth, due to its high population base and growth in awareness about the benefits of needle-free injections and their application in treatment of cancer, diabetes, and other infectious diseases. However, high development costs of needle-free injection systems over traditional needle injection are likely to impede the market growth during the forecast period.
This report focuses on Needle-Free Injectors volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Needle-Free Injectors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Needle-Free Injectors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Liquid-based
Powder-based
Segment by Application
Hospitals & Clinics
Home Care Settings
Research Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Antares Pharma
Pharma Jet
Bioject Medical Technologies
Medical International Technology
INJEX Pharama
European Pharma Group
PenJet Corporation
Crossject
Due to the COVID-19 pandemic, the global Needle-Free Injectors market size is estimated to be worth US$ 206.4 million in 2021 and is forecast to a readjusted size of US$ 398.3 million by 2028 with a CAGR of 9.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Needle-Free Injectors market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Needle-Free Injectors landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Rise in prevalence of diabetes raises the demand for needle-free insulin delivery devices. Asia-Pacific offers lucrative opportunities for the market growth, due to its high population base and growth in awareness about the benefits of needle-free injections and their application in treatment of cancer, diabetes, and other infectious diseases. However, high development costs of needle-free injection systems over traditional needle injection are likely to impede the market growth during the forecast period.
This report focuses on Needle-Free Injectors volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Needle-Free Injectors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Needle-Free Injectors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Liquid-based
Powder-based
Segment by Application
Hospitals & Clinics
Home Care Settings
Research Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Antares Pharma
Pharma Jet
Bioject Medical Technologies
Medical International Technology
INJEX Pharama
European Pharma Group
PenJet Corporation
Crossject
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
